Form 8-K - Current report:
SEC Accession No. 0001404644-25-000103
Filing Date
2025-11-13
Accepted
2025-11-13 17:11:08
Documents
52
Period of Report
2025-11-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ngne-20251113.htm   iXBRL 8-K 27722
2 EX-99.1 ngne_3q25earningsreleasexf.htm EX-99.1 26990
3 EX-99.2 a202511_ngnecorporatepre.htm EX-99.2 43275
7 a202511_ngnecorporatepre001.jpg GRAPHIC 114818
8 a202511_ngnecorporatepre002.jpg GRAPHIC 295458
9 a202511_ngnecorporatepre003.jpg GRAPHIC 133414
10 a202511_ngnecorporatepre004.jpg GRAPHIC 60982
11 a202511_ngnecorporatepre005.jpg GRAPHIC 130424
12 a202511_ngnecorporatepre006.jpg GRAPHIC 37907
13 a202511_ngnecorporatepre007.jpg GRAPHIC 120018
14 a202511_ngnecorporatepre008.jpg GRAPHIC 120896
15 a202511_ngnecorporatepre009.jpg GRAPHIC 129988
16 a202511_ngnecorporatepre010.jpg GRAPHIC 36416
17 a202511_ngnecorporatepre011.jpg GRAPHIC 134609
18 a202511_ngnecorporatepre012.jpg GRAPHIC 133540
19 a202511_ngnecorporatepre013.jpg GRAPHIC 173704
20 a202511_ngnecorporatepre014.jpg GRAPHIC 30297
21 a202511_ngnecorporatepre015.jpg GRAPHIC 91029
22 a202511_ngnecorporatepre016.jpg GRAPHIC 118836
23 a202511_ngnecorporatepre017.jpg GRAPHIC 73493
24 a202511_ngnecorporatepre018.jpg GRAPHIC 122915
25 a202511_ngnecorporatepre019.jpg GRAPHIC 93945
26 a202511_ngnecorporatepre020.jpg GRAPHIC 86838
27 a202511_ngnecorporatepre021.jpg GRAPHIC 133760
28 a202511_ngnecorporatepre022.jpg GRAPHIC 126610
29 a202511_ngnecorporatepre023.jpg GRAPHIC 101802
30 a202511_ngnecorporatepre024.jpg GRAPHIC 94759
31 a202511_ngnecorporatepre025.jpg GRAPHIC 53714
32 a202511_ngnecorporatepre026.jpg GRAPHIC 78789
33 a202511_ngnecorporatepre027.jpg GRAPHIC 125943
34 a202511_ngnecorporatepre028.jpg GRAPHIC 120873
35 a202511_ngnecorporatepre029.jpg GRAPHIC 112985
36 a202511_ngnecorporatepre030.jpg GRAPHIC 33822
37 a202511_ngnecorporatepre031.jpg GRAPHIC 107350
38 a202511_ngnecorporatepre032.jpg GRAPHIC 26267
39 a202511_ngnecorporatepre033.jpg GRAPHIC 138168
40 a202511_ngnecorporatepre034.jpg GRAPHIC 90505
41 a202511_ngnecorporatepre035.jpg GRAPHIC 82659
42 image_0.jpg GRAPHIC 44141
43 image_1.jpg GRAPHIC 56200
44 image_2.jpg GRAPHIC 3474
  Complete submission text file 0001404644-25-000103.txt   5439233

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ngne-20251113.xsd EX-101.SCH 1788
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ngne-20251113_lab.xml EX-101.LAB 22548
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ngne-20251113_pre.xml EX-101.PRE 13050
54 EXTRACTED XBRL INSTANCE DOCUMENT ngne-20251113_htm.xml XML 2802
Mailing Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011
Business Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011 (877) 237-5020
Neurogene Inc. (Filer) CIK: 0001404644 (see all company filings)

EIN.: 980542593 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36327 | Film No.: 251479713
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)